The infectious hematopoietic necrosis virus (IHNV; Rhabdoviridae, Novirhabdovirus) infects teleost fish, such as salmon and trout, and is responsible for a severe systemic disease that causes catastrophic losses in the aquaculture industry and wild fish populations. Rhabdoviruses are characterized by a single-stranded, negative-sense RNA genome, and an envelope consisting of trimers of a glycoprotein that displays N-linked oligosaccharides, and plays an integral role in the pathogenesis of viral infection. Although it has been recently proposed that IHNV enters the host through the skin at the base of the fins, the viral adhesion and entry mechanisms are not fully understood. In recent years, evidence has accumulated in support of the key roles played by protein-carbohydrate interactions between host lectins and virion envelope glycoproteins in modulating viral adhesion and infectivity. Galectins, which constitute a conserved and ubiquitous lectin family defined by a unique amino acid sequence motif and their preferential binding to galactosyl moieties, have been described as mediators of developmental processes and key immunoregulatory factors. However, they can also recognize glycans on the surface of potential pathogens and function as pattern recognition receptors in innate immunity. In this study, we used a zebrafish (Danio rerio) proto type galectin-1 (Drgal1-L2) and a chimera galectin-3 (Drgal3-L1) as a model to assess in vitro the potential role(s) of the host's galectins in viral infectivity for epithelial cells. Our results suggest that exposure to IHNV transiently upregulates galectin expression in fish epithelial cells during the early stages of infection, and that the extracellular Drgal1-L2 and Drgal3-L1 interact directly with the IHNV glycosylated envelope in a carbohydrate-dependent manner significantly reducing viral adhesion. A preliminary glycosylation study of the IHNV envelope glycoprotein identified oligosaccharides that may potentially constitute the galectin ligands responsible for the observed inhibition of viral adhesion to the host.
Introduction
Viral infections cause severe diseases in farmed and wild fish populations and have a detrimental impact in the aquaculture industry and the environment. Both rhabdoviruses, such as the infectious hematopoietic necrosis virus (IHNV), snakehead rhabdovirus (SHRV) and viral hemorrhagic septicemia virus (VHSV), and birnaviruses such as the infectious pancreatic necrosis virus (IPNV) are responsible for massive losses of fish in both wild and farmed salmon and trout species by highly pathogenic local and systemic infections that lead to significant morbidity and mortality (Wolf 1988; Crane and Hyatt 2011; Purcellet et al. 2012 ).
Rhabdoviruses are characterized by a single-stranded, negative-sense RNA genome, and an envelope consisting of trimers of a glycoprotein that displays multiple N-linked oligosaccharides and plays an integral role in the pathogenesis of viral infection. IHNV (family Rhabdoviridae, genus Novirhabdovirus type species) infects teleost fish, such as salmon and trout, and is responsible for catastrophic losses in the aquaculture industry. The genome of IHNV encodes for six gene products, the nucleocapsid (N), phosphoprotein (P), matrix protein (M), envelope glycoprotein (G), non-virion protein (NV) and polymerase or large protein (L), and is organized in the following order: 3'-leader-N-P-M-G-NV-Ltrailer-5'. Three major genetic groups of North American IHNV isolates have been defined based on their envelope protein sequence similarity, designated as the U, M, and L genogroups. The M genogroup is endemic in the rainbow trout farming region in Idaho, where phylogenetically distinct sub-groups, designated MA-MD have been reported. The MB, MC, and MD sub-groups are the three most prevalent and widely distributed types of IHNV in the virus-endemic region, and they have been shown to cocirculate in the field for over 20 years (Troyer and Kurath 2003) .
IHNV infections spread throughout fish populations by waterborne transmission (Batts et al. 1991) , as the virus shed by the infected animals into the water enters the new host, and soon infections can be detected in gills, esophagus and cardiac stomach (Chilmonczyk and Monge 1980; Helmick et al. 1995) The primary infection site(s) of IHNV have not been rigorously identified but it has been proposed that the virion enters the host through the skin at the base of the fins (Harmache et al. 2006) . The viral adhesion and entry mechanisms, however, are not fully understood but a unique fibronectin has been identified as an IHNV attachment factor present at the cell surface (Liu and Collodi 2002) .
In recent years, evidence has accumulated in support of the key roles played by protein-carbohydrate interactions between host lectins and virion envelope glycoproteins in modulating viral adhesion and infectivity. Glycans on the viral surface can be recognized by host lectins that function as pattern recognition receptors (PRRs) that signal to activate and regulate the appropriate innate and adaptive immune responses (Barrionuevo et al. 2007; Jeon et al. 2010) . However, multiple examples reveal that co-evolution of host-pathogen consortia has led to subversion of the immune recognition roles of lectins to facilitate adhesion and entry of the pathogens into the host cells (Kamhawi et al. 2004; Ouellet et al. 2005; Okumura et al. 2008; Yang et al. 2011) . Galectins are good examples of these opposing recognition functions of lectins that may be either beneficial for the host in their roles as PRRs, but also detrimental by functioning as facilitators of viral, bacterial, and parasitic infection (Tasumi and Vasta 2007; Nieminen et al. 2008; Stowell et al. 2008; Vasta 2009; St-Pierre et al. 2011; Yang et al. 2011; Vasta 2012) Galectins comprise an evolutionary conserved family of ß-galactoside binding proteins, ubiquitous in mammals and other vertebrate taxa, invertebrates, and fungi. Galectins are defined by a unique sequence motif in their carbohydrate-recognition domains (CRDs), and are classified into three major structural types: (i) proto-type galectins, which contain one CRD and form homodimers; (ii) chimera-type galectins, which have a single CRD and can oligomerize forming trimers and pentamers; (iii) tandemrepeat-type galectins, which are characterized by two CRDs joined by a linker peptide (Vasta and Ahmed 2008) . Since their discovery in the 1970s, their biological roles, initially understood as limited to the recognition of cell surface glycans in embryogenesis and early development (Camby et al. 2006) , have expanded in recent years by the discovery of their immunoregulatory activities (Rabinovich and Toscano 2009) . A gradual paradigm shift has taken place in the past few years through the realization that galectins also bind glycans on the surface of potentially pathogenic microbes, and function as recognition and effector factors in innate immunity (Stowell et al. 2010) . Galectins can function as PRRs, recognizing various pathogen-associated molecular patterns (PAMPs) such as glycans, like lipopolysaccharides (LPS) and peptidoglycan on the surface of pathogenic microbes, parasites, and fungi (Vasta 2012) . Most galectins are either bivalent or multivalent with regard to their carbohydrate-binding activities, which enable the simultaneous recognition of multiple binding partners ("self" or "non self").
This suggests that galectins can act as bridging molecules between immune cells such as phagocytes and their targets, acting as opsonins (Karlsson et al. 2009 ) or between microbes and other host cells modulating the immune response (Rabinovich and Toscano 2009; Vasta 2009; Davicino et al. 2011 ).
Galectins of all three structural types have been identified and characterized in various tissues, plasma and mucus of teleost fish, and their roles in recognition of bacterial pathogens has been reported for multiple fish species (Vasta et al. 2011) .
In this study, we use the zebrafish (Danio rerio) proto type galectin-1 (Drgal1-L2) and chimera galectin-3 (Drgal3-L1) as a model to assess in vitro the potential role(s) of the host's galectins in viral infectivity for epithelial cells. Our results suggest that exposure to IHNV upregulates galectin expression in fish epithelial cells, and that the extracellular Drgal1-L2 and Drgal3-L1 interact directly with the IHNV glycosylated envelope in a carbohydrate-dependent manner, as well as with galactosyl moieties on the epithelial cell surface, significantly reducing viral adhesion. A preliminary glycosylation study of the IHNV envelope glycoprotein identified oligosaccharides that may potentially constitute the galectin ligands responsible for the observed inhibition of viral adhesion to the host.
Materials and Methods

Cell cultures:
The epithelial EPC (epithelioma papulosum cyprini) cell line (CRL-2872, ATCC) from the fathead minnow Pimephales promelas was grown in minimal essential medium (MEM; Cellgro) supplemented with 10% fetal bovine serum (FBS; Quality Biological), 2 mM L-glutamine and penicillin-streptomycin at 26 °C. The ZFL (zebrafish liver) cell line was grown in Leibovitz's L-15 medium supplemented with penicillin-streptomycin at 28 °C. All cell lines were grown in an atmosphere of 100% air with humidification.
Virus purification and labeling:
The infectious clone of IHNV strain 220-90 was propagated by multiple passages on confluent layers of EPC cells. In brief, confluent EPC cells grown in 75 cm 2 flasks at 26 °C were infected at a multiplicity of infection (MOI) of 0.1 in the presence of MEM and 2% FBS.
The infection was allowed to proceed at 16 °C until extensive cytopathic effect (CPE) was observed.
The supernatant was harvested 3-4 days post-infection (dpi), clarified by low-speed centrifugation, then separated on a discontinuous cesium chloride gradient by ultracentrifugation at 28,000×g. The banded virus was resuspended in TEN buffer (1 mM EDTA, 10 mM Tris-HCl, 1 M NaCl, pH 7.4) and stored at −80°C. Virus titers were measured by endpoint dilution on EPC cells (Burke and Mulcahey 1980) . For biotinylation, the 1× TEN buffer was exchanged with phosphate-buffered saline (PBS) by overnight dialysis at 4-8 ºC prior to the purified recombinant virus being reacted with 1 mg/mL EZ-Link Sulfo-NHS-Biotin (Pierce) in accordance with the manufacturer's recommendations.
Expression and purification of recombinant zebrafish galectins:
The cloning of the zebrafish galectins has been described elsewhere ). Histidine-tagged recombinant Drgal1-L2 (Genbank accession no. AY421704) and Drgal3-L1 (Genbank accession no. AY421705) were separately expressed from the pET-28b(+) vectors in transformed Rosetta (DE3)pLysS competent cells (Novagen).
Plasmid-carrying cells were grown in Luria-Bertani (LB) broth with antibiotics (chloramphenicol, 34 μg/ml; kanamycin, 15 μg/ml) to an OD600 of 0.600 at which time recombinant protein expression was induced with the addition of 0.1 mM isopropyl D-thiogalactoside (IPTG) for 16 h at 23 °C. After pelleting, the soluble protein fraction was extracted with BugBuster Protein Extraction Reagent (Novagen) containing 1 mM phenylmethylsulfonyl fluoride (PMSF), 1× Protease Inhibitor Cocktail Set I (Calbiochem), 20 μg/ml lysozyme, 25 U/ml Benzonase Nuclease (Novagen) and 0.07% β-mercaptoethanol (BME). The clarified soluble fraction was loaded onto a pre-equilibrated chromatography column packed with 4 ml of divinyl sulfone-conjugated lactosyl-Sepharose slurry.
After rinsing the column thoroughly with wash buffer (1:10 PBS, 0.07% BME), the galectins were eluted with elution buffer (1:10 PBS, 0.07% BME, 100 mM lactose). Glycerol was added to a final concentration of 50% (v/v); stocks were made and stored at −20 ºC.
Binding of zebrafish galectins to IHNV:
Binding of recombinant zebrafish galectins (Drgal1-L2 and Drgal3-L1) to IHNV was detected by ELISA. A 96-well microtiter plate was coated with 1 μg/well of recombinant Drgal1-L2 or Drgal3-L1 in coating buffer (15 mM sodium carbonate, 85 mM sodium bicarbonate, pH 9.6) overnight at 4-8 °C overnight in the presence of 100 mM lactose to stabilize the CRD binding pocket and 10 mM BME to prevent oxidation. As a negative control, the remaining wells were coated with 1 μg of BSA in PBS. The plate was washed with cold PBS/lactose/BME and incubated with blocking buffer diluted in PBS/lactose/BME for 8 h at 4-8 °C. The plate was then washed 6 times with PBS/10 mM BME (PBS/BME) and incubated with serial dilution of the purified viral preparation overnight at 4-8 °C. After three washes with PBS/BME, the plate was fixed with 2% paraformaldehyde for 1.5 h at room temperature. The wells were washed extensively with PBS to remove formaldehyde. Binding of the virus to galectins was detected by incubation with a 1:1000 dilution of anti-IHNV rabbit antiserum followed by horseradish peroxidase (HRP)-conjugated antirabbit IgG. The plate was developed using TMB substrate (KPL) for HRP and the reaction was stopped by adding 1 M hydrochloric acid (HCl). Absorbance measurements were read on a SpectraMax plate analyzer at a 450 nm wavelength. The inhibition of IHNV binding to recombinant zebrafish galectins by free monosaccharides and disaccharides was carried out in presence of sugars prepared at 100 mM (lactose, sucrose, glucose or N-acetyllactosamine). After blocking, the plate was incubated with increasing amounts of purified virus with or without sugars. The assay was then conducted as described above. Western blot: Cell lysates and supernatant precipitates were fractionated on a 10% SDS-PAGE gel and transferred to a PVDF membrane. The membranes were blocked with 5% non-fat dry milk for 1 h at room temperature, then incubated with a 1:1000 dilution of purified polyclonal rabbit immunoglobulins specific for zebrafish galectins Drgal1-L2 and Drgal3-L1 (Open Biosystems) overnight at 4-8 ºC.
Assessment of IHNV infection on galectin levels and secretion in fish cell
Indirect detection was carried out with a 1:1000 dilution of HRP-conjugated anti-rabbit IgG. All membranes were developed using Western Lightning Plus-ECL reagent (PerkinElmer) followed by exposure to autoradiography film.
Detection and identification of viral proteins by Western blot:
Whole purified IHNV was fractionated on a 10% SDS-PAGE gel and transferred to PVDF membranes as described above. The membranes were blocked with 5% non-fat dry milk for 1 h at room temperature, then incubated with a 1:1000 dilution of polyclonal rabbit antisera specific for IHNV strain 220-90 overnight at 4-8 ºC. Indirect detection and development were carried out as described above.
Glycotyping of viral glycoprotein(s) by a lectin overlay binding assay:
For the characterization of the glycosylation of viral components, whole purified IHNV was separated on a 10% SDS-PAGE gel and transferred to PVDF membranes as described above. Glycosylated viral components were detected with the Glycoprotein Staining Kit (Thermo Scientific). The detection and preliminary characterization of specific carbohydrates on the IHNV envelope were carried out using digoxigenin (DIG)-labeled lectins from the DIG Glycan Differentiation Kit (Roche).
Fractionation and isolation of the viral glycoprotein:
The IHNV envelope glycoprotein was isolated by affinity chromatography on a column consisting of Datura stramonium agglutinin conjugated to agarose (DSA-agarose, EY Laboratories), subsequently subjected to immunoprecipitation using the Classic IP Kit (Pierce) in conjunction with polyclonal anti-IHNV antibody, and finally analyzed by SDS-PAGE and Western blot.
Galectin binding to the isolated viral glycoprotein:
The binding of the zebrafish galectins Drgal1-L2
and Drgal3-L1 to the isolated viral glycoprotein fraction was assessed by the lectin overlay binding assay as described above, with the PVDF membrane strips displaying the isolated viral glycoprotein probed with recombinant Drgal1-L2 and Drgal3-L1, followed by anti-Drgal1-L2 and anti-Drgal3-L1
antibodies. Binding of DSA was assessed similarly using a DSA-HRP conjugate (EY Laboratories).
N-glycosidase F and endoglycosidase H treatment of the viral glycoprotein:
In order to release the Nlinked glycans from the sample, whole purified IHNV was digested with 100 U of either PNGase F or EndoH (New England Biolabs) for 1 h at 37 o C and further analyzed for lectin binding after separation on a 10% SDS-PAGE gel and transfer to a PVDF membrane. Control samples were incubated without enzymes.
Glycomics analysis of the EPC cell line:
This was carried out as described elsewhere (Jang-Lee et al.
2006
). Briefly, cells were homogenized in an extraction buffer of 1% CHAPS (v/v) in 25 mM Tris, 150 mM NaCl, 5 mM EDTA in water, pH 7.4 and subsequently dialyzed against a 50 mM ammonium bicarbonate buffer. Glycoproteins were reduced, carboxymethylated and tryptic-digested prior to the release of protein linked N-glycans by PNGase F (Roche Applied Science) digestion. Released Nglycans were permethylated prior to MS analysis.
Glycoproteomic analysis:
The IHNV glycoproteins were first isolated by DSA-agarose affinity followed by a second round of purification by immunoprecipitation with antibody against IHNV as described above. The viral glycoprotein interacting with zebrafish galectins was cut out for glycopeptide MS identification carried out as described elsewhere (Harrison, Hitchen et al. 2012) . Briefly, gel bands were excised and destained using 50 mM ammonium hydrogen carbonate (Sigma-Aldrich) mixed with an equal amount of acetonitrile (Romil). The samples in the gel pieces were reduced and carboxymethylated by dithiothreitol (Roche Applied Science, East Sussex, UK) and iodoacetic acid (Sigma-Aldrich). They were then digested by trypsin (Promega) and the supernatant, which contained (glyco)peptides, was transferred to a new tube. The (glyco)peptides remaining in the gel were extracted using 0.1% (v/v) trifluoroacetic acid (Romil), followed by acetonitrile. The supernatants were combined and concentrated for mass spectrometric analysis. Online nanoLC-MS was run on an API QSTAR Pulsar Hybrid LC/MS/MS system (Applied Biosystems/MDS Sciex). The data were analyzed using Analyst QS Software (Applied Biosystems). 
Binding of zebrafish galectins to EPC cells:
Statistical analysis:
The mRNA and protein expression levels were quantified using Image J software to estimate the relative band intensities. Comparison of two groups was performed by Student's T-test for the comparison of non-paired samples. All results with p<0.05 were considered statistically significant.
Results
Our prior studies have shown that the zebrafish represents a suitable model system to elucidate the functional aspects of galectins in both development and immunity (Vasta et al. 2004; Vasta and Ahmed 2008; Ahmed et al. 2009; Feng et al. 2015) . however, we compared the expression and secretion of the zebrafish Drgal1-L2 and Drgal3-L1 in the ZFL with those from the EPC epithelial cell line (Fig 1) . Our study by PCR on total RNA, and by
Western blot on cell lysates and the culture supernatants not only confirmed that the EPC cell line expresses galectins of similar sequence and cross-reactive with the zebrafish Drgal1-L2 and Drgal3-L1 (Fig. 1A, B) , but also that these galectins are similarly secreted to the extracellular environment at comparable levels by the two cell lines (Fig. 1C) .
Exposure of fish epithelial cells (EPC) to IHNV modulates of galectin expression:
Based on our observations that galectins of similar sequence are synthesized and secreted by the ZFL and EPC cells, we examined the potential effects of IHNV exposure on their transcription. Exposure of EPC cells to IHNV revealed only slight to moderate increases in DrGal1-L2 and DrGal3-L1 expression during the first 12h, followed by a downregulation of expression at 24h (70-80% of the unexposed controls), reaching about 10-15% of the controls at 48h, a time point in the experimental exposure that coincides with the full-fledged infection, in which all cells in the field show expression of viral proteins (Fig. 2) .
Recombinant zebrafish galectins Drgal1-L2 and Drgal3-L1 bind to IHNV envelope in a dosedependent and carbohydrate-specific manner:
Given that the epithelial cells express and secrete protoand chimera type galectins to the extracellular space, we investigated whether these galectins could bind to the IHNV glycosylated envelope. For this, we tested the binding of the recombinant Drgal1-L2-and Drgal3-L1 to intact IHNV virions in a "capture" format ELISA. Our results revealed that both Drgal1-L2-and Drgal3-L1 recognized the IHNV virus in a dose-response manner, although the latter showed a significantly stronger binding at the three concentrations tested, and greatest difference in IHNV binding with Drgal1-L2 at 0.25 μg protein/well (Fig. 3A) . Based on these results we tested the carbohydrate specificity of the galectin-virion interactions by a binding-inhibition capture ELISA, in which the potential inhibitory effects of the disaccharides N-acetyllactosamine (LacNAc), lactose, and sucrose were examined ( Fig. 3B-D) . The most effective inhibitor for the interactions of both Drgal1-L2 and Drgal3-L1 with IHNV was N-acetyllactosamine, although it was significantly more effective for Drgal1-L2 than for Drgal3-L1: while only 0.5 mM was required for 50% inhibition for Drgal1-L2 binding to IHNV, a 3-fold higher concentration (1.5 mM) was required for Drgal3-L1 (Fig. 3B) . In contrast, lactose concentrations of 30 mM and 60 mM were required for 50% inhibition of Drgal3-L1 and Drgal1-L2, respectively ( Fig. 3C) , while sucrose had a negligible inhibitory effect on both galectins (Fig. 3D ).
These results confirmed that the binding of the zebrafish galectins Drgal1-L2 and Drgal3-L1 to IHNV is carbohydrate-dependent and can be specifically blocked in a concentration-dependent manner by disaccharides that we have previously shown as high (LacNAc) or moderate (lactose) affinity ligands for these galectins ).
Identification of galectin ligands on the IHNV envelope:
To elucidate the structural basis of the interactions between Drgal1-L2 and Drgal3-L1 with IHNV, we first characterized the carbohydrates present on IHNV proteins via the binding of a set of DIG-labeled plant lectins of well-established carbohydrate specificity. These included GNA, specific for terminally linked mannose, MAA, that binds sialic acid terminally linked in α2-3 to galactose, PNA, that binds galactose in β(1-3)-GalNAc, SNA, that is specific for sialic acid terminally linked in α2-6 to galactose or GalNAc, and Galβ(1-4)-GlcNAc, and DSA, that binds GlcNAc oligosaccharides and Galβ(1-4)-GlcNAc. The results revealed that, except
for PNA, all lectins tested recognized the envelope glycoprotein (not shown), indicating that it displays complex or hybrid type N-linked oligosaccharides that are sialylated via both 2-3 or 2-6 linkages to the non-reducing terminal sugar moiety, most likely galactose.
To confirm our findings from the IHNV glycotyping, we subjected the virions to treatment with the glycosidases PNGase F and Endo H and assessed the results by analyzing DSA binding and potential shifts in the mobility of the envelope glycoprotein. While PNGase F cleaves the bonds between the basal GlcNAc and asparagine residues of high mannose, hybrid, and complex oligosaccharides from N-linked glycoproteins, Endo H cleaves glycosidic linkages within the chitobiose core of high mannose and hybrid oligosaccharides. The PNGase F treatment abolished the recognition of the IHNV glycoprotein by DSA (Fig. 4A, lane "F") , and increased the electrophoretic mobility of the IHNV glycoprotein, most visibly in the band corresponding to the glycoprotein monomer (58 kDa band) (Fig. 4B, lane "F Finally, we examined by Western blot analysis the recognition of the affinity/immunoprecipitationglycoprotein purified IHNV envelope glycoprotein by the zebrafish galectins Drgal1-L2 and Drgal3-L1.
Indeed, the IHNV glycoprotein was not only strongly recognized by the anti-IHNV antibodies and DSA, but also by Drgal1-L2 and Drgal3-L1 (Fig. 4C) , indicating that the aforementioned terminal galactose-β(1-4)-N-acetylglucosamine moieties in complex N-linked oligosaccharides decorating the IHNV envelope are the most likely Drgal1-L2 and Drgal3-L1 ligands responsible for the galectin-IHNV specific interactions previously identified (Fig. 3) .
Glycosylation analysis of the EPC cell line and the IHNV envelope glycoprotein revealed potential galectin ligands:
To obtain information on the types of oligosaccharide that are expressed on the IHNV envelope, we carried out glycomic profiling of the EPC cell line together with a glycoproteomics analysis of an IHNV glycoprotein sample. Although the dominant glycans expressed by the EPC cells were found to be high mannose in our glycomics experiment, a significant minority of the glycans are complex-type and some of the latter have N-acetyllactosamine antennae that are potential galectin ligands (Fig. 5A) . Importantly, our glycoproteomics analysis of the IHNV glycoprotein sample, revealed a glycopeptide which was solely glycosylated with complex-type glycans ( (Fig. 6A) . A comparative analysis of the binding of Drgal1-L2 and Drgal3-L1 at two concentrations (15 µ g/ml and 30 µ g/ml) confirmed that both recombinant Drgal1-L2 and Drgal3-L1 bound in a dose-response manner to the surface of the epithelial cells (Fig. 6B) . A preliminary study to examine whether endogenous galectins secreted by the EPC cells into the culture medium could bind to the cell surface was carried out by exposing the cells to culture medium containing 100 mM lactose to displace any cell surface-bound endogenous galectins prior to adding the exogenous recombinant Drgal1-L2 to the culture. The results showed a 10-20% increase in binding of the exogenous Drgal1-L2 (not shown), suggesting that as the cells grow in culture and secrete galectins to the extracellular space, these may remain bound to the cell surface.
Pre-incubation of recombinant Drgal-1 or Drgal-3 with IHNV inhibits viral adhesion to the host cell surface. Finally, the observations that both Drgal1-L2 and Drgal3-L1 recognized the IHNV envelope glycoprotein, and strongly bound to the epithelial cell surface led us to inquire whether the zebrafish galectins either facilitate IHNV infection by cross-linking the virus to the cell surface or prevent infection by hindering viral adhesion. Thus, we investigated the effect of binding of zebrafish galectins to the IHNV on adhesion of the virions to the surface of epithelial cells by pre-incubating the biotinylated IHNV with either Drgal1-L2 or Drgal3-L1 for 1 hour, before adding the virus to the EPC culture. Our results indicate that pre-exposure of IHNV to extracellular Drgal1-L2 or Drgal3-L1 significantly decreased the viral adhesion to the EPC cells (Fig. 7) . Pre-incubation of IHNV with 30μg/ml recombinant Drgal1-L2 decreased IHNV binding to EPC cells by over 40% relatively to the unexposed controls, whereas Drgal3-L1 had a more dramatic effect, decreasing IHNV binding to EPC cells by approximately 65% (Fig. 7) .
Discussion
Although some galectin family members have been shown to participate in early embryogenesis and developmental processes (Camby et al. 2006 ), limited information is currently available concerning their potential roles in infectious disease (Vasta 2009; Vasta et al. 2012) . In recent years, however, evidence has accumulated not only in support of the role(s) of some galectins as PRRs (Vasta 2009; Vasta 2012 ), but also as effectors displaying bacteriocidal activity (Stowell et al. 2010) . Furthermore, some pathogens have co-evolved with their hosts to take advantage of the recognition functions of their galectins to facilitate entry and infection (Pelletier et al. 2003; Tasumi and Vasta 2007; Okumura et al. 2008; Feng et al. 2013) . Fragmentary evidence suggests that in mammals, selected galectin types can mediate very different mechanisms to elicit protective functions during microbial infections (Farnworth et al. 2008; Yang et al. 2011) . For example, Gal3 mediates neutrophil recruitment into the lung in an integrinindependent manner upon pneumococcal infection (Sato et al. 2002; Nieminen et al. 2008) . In contrast, Gal1 directly inhibits hemagglutination activity and infectivity of influenza A virus by binding its envelope glycoproteins and suppresses virus-induced cell death (Yang et al. 2011) .
In this study we investigated the potential role(s) of galectins as PRRs in IHNV infection using the zebrafish as a model system. The initial studies for the identification and characterization of galectins in zebrafish ) had revealed that this teleost species expresses a diverse galectin repertoire that consists of the same proto, chimera and tandem repeat structural types that have been defined in the mammals (Cooper 2002) . In this study we tentatively selected their zebrafish homologues, Drgal1-L2 and Drgal3-L1, to examine their potential role(s) in pathogen recognition and entry. The expression and secretion of zebrafish Drgal1-L2 and Drgal3-L1 galectin homologues by the epithelial cell line EPC and the zebrafish also confirmed its suitability for in vitro studies aimed at investigating the potential effect of fish galectins secreted by epithelial cells on IHNV infectivity. The skin of teleost fish is covered by mucus secreted by specialized mucous glands, and galectins secreted by these glands as well as epithelial cells have been identified and their binding activity demonstrated in several studies (Suzuki et al. 2003; Tasumi et al. 2004; Takayama et al. 2009 ). Our observation that exposure of the fish epithelial cells to IHNV modulates the expression of galectin-like proteins, is suggestive of potential interactions between these proteins and the virions. Recently, human galectins have been shown to be induced in vivo in response to several different viral infections, including influenza (Katoh et al. 2014) , Nipah (Garner et al. 2014) , and human immunodeficiency virus (Tandon et al. 2014 ).
The finding that both Drgal1-L2 and Drgal3-L1 recognized and bound the IHNV virion glycosylated envelope was strongly suggestive of a role in the teleost antiviral defensive mechanisms, and we focused subsequent studies on the structural basis of the galectin-ligand recognition. The results confirmed that the binding of the zebrafish galectins Drgal1-L2 and Drgal3-L1 to IHNV is carbohydrate-dependent and can be specifically blocked in a concentration-dependent manner by the disaccharides LacNAc or lactose, but not with sucrose. In a previous study we had shown that LacNAc behaves as a high affinity ligands for zebrafish galectins, whereas lactose is less effective ).
Glycotyping with plant lectins and enzymatic treatment with glycosidases revealed that the IHNV envelope glycoprotein displays complex or hybrid type N-linked oligosaccharides that are sialylated via both 2-3 or 2-6 linkages to the non-reducing terminal sugar moiety, most likely Gal. The lack of binding by PNA, which preferentially recognizes Galβ(1-3)GalNAc, together with strong binding by DSA, which in addition to chitobiose binds to Galβ(1-4)GlcNAc provided the structural basis for the observation that the envelope glycoprotein is effectively recognized by both Drgal1-L2 and Drgal3-L1, and that these interactions can be most effectively inhibited by LacNAc. The preliminary glycosylation analysis of the IHNV purified envelope glycoprotein by mass spectrometry revealed the presence of complex biantennary N-glycan structures containing non-reducing terminal LacNAc. These structures were also present in the glycome of the uninfected fish epithelial cells, suggesting that like other viruses (Mercier et al. 2008; St-Pierre et al. 2011; Yang et al. 2011) , IHNV takes advantage of the glycosylation systems of the host cells in which it replicates.
Upon the observations that both Drgal1-L2 and Drgal3-L1 bind to the IHNV envelope glycoprotein, and also effectively bind to the epithelial cell surface it became of interest to investigate if these galectins could either prevent infection by hindering viral adhesion as shown for the influenza virus (Yang et al. 2011) or facilitate viral adhesion by cross-linking the virus to the cell surface as proposed for HIV (Sato and Nieminen 2004 ). At the concentrations tested, both Drgal1-L2 and Drgal3-L1 inhibited IHNV infection of the epithelial cells, suggesting that both may function by coating the virus envelope and interfering with the viral adhesion mechanisms, such as that mediated by the truncated fibronectin identified as the IHNV co-receptor on the zebrafish cell surface (Liu and Collodi 2002) . However, it is also possible that by partially coating the host cell surface, the galectins also contribute to hinder, sterically or specifically, the cell surface sites to which the IHNV virions adhere. The relatively higher degree of inhibition of viral adhesion observed for Drgal3-L1 as compared to Drgal1-L2, was consistent with Drgal3-L1's more effective binding to the epithelial cell surface. Further, fibronectin is a glycoprotein that is recognized as an effective galectin ligand (Ozeki et al. 1995) . Thus, our results suggest the possibility that both galectins may inhibit IHNV adhesion by coating the virions surface glycoproteins, as well as the truncated fibronectin co-receptor. In some teleost fish species, galectins have been shown to participate in innate immune mechanisms against eukaryotic parasites, bacteria, and viruses. In conger eel (Congeer myriaster) both isotypes of congerin, a proto-type galectin, participate in cellular encapsulation of the parasitic nematode (Cucullanus spp.) via the induction of cellular adhesion to the parasites through galectin-glycan recognition Watanabe et al. 2012) . Other examples have revealed direct and specific interactions of fish galectins with the pathogens (Tasumi et al. 2002; Tanguy et al. 2004; Dutta et al. 2005) and by controlling virulence and viral replication rate by modulating the viral adhesion to the host (Poisa-Beiro et al. 2009; Liu et al. 2013) . Current studies in our laboratory are aimed at elucidating the mechanisms involved in the modulation of viral adhesion by Drgal1-L2 and Drgal3-L1, and other galectins from the zebrafish repertoire. Relative levels of Drgal1-L2 and Drgal3-L1 mRNA transcript were measured at various timepoints, indicated as hours post-infection (hpi) with IHNV. All threshold cycle (C T ) values were normalized to 18S rRNA endogenous controls. Relative fold changes in gene expression were calculated using the −ΔΔC T method (Livak and Schmittgen 2001) . The log(10)-transformed fold changes were evaluated in a two sided t test. The derived p values less than 0.05 were considered to be significantly different. Putative structures are based on composition, tandem MS, and the biosynthetic knowledge (B) Electrospray mass spectrum of a glycopeptide from IHNV envelope glycoproteins. EPC viral glycoproteins were purified on a DSA-agarose column followed by immunoprecipitation with anti-IHNV antibodies. Purified viral glycoproteins were separated by SDS-PAGE and the glycoproteins that were recognized by Drgal1-L2 and Drgal3-L1 in a Western blot were excised from the gel for glycoproteomics analysis. Glycopeptide molecular ions are annotated with sugar sequences that are inferred from their compositions and biosynthetic knowledge. Signals marked with a cross are not glycopeptides.
Fig 6.
Recombinant zebrafish galectins Drgal-1 and Drgal-3 bind to the surface of EPC cells. The binding of Drgal1-L2 to the EPC cell surface was quantified by ELISA, with Drgal1-L2 binding to asialofetuin as a reference. EPC cultured in ELISA plates (EPC) or asialofetuin coated plates (ASF) were incubated with Drgal1-L2 (0-30 μg/ml) (A); or EPC cultured in ELISA plates were incubated with 15 or 30 μg/ml of recombinant Drgal1-L2 and Drgal3-L1 (B). The binding of by Drgal1-L2 and Drgal3-L1 was detected with rabbit antibodies against specific galectins followed by HRP-conjugated antirabbit antibody. Nonspecific background absorbance (cells only) was subtracted from the absorbance values. The fold change in binding of recombinant Drgal1-L2 and Drgal3-L1 to EPC is shown relative to the unexposed cells (B). Data shown and the bar graphs are representative data from at least three independent experiments. *p <0.05; **p<0.001. 
